share_log

Cantor Fitzgerald Initiates Coverage On Novo Nordisk With Overweight Rating, Announces Price Target of $120

Benzinga ·  Dec 1, 2023 08:49

Cantor Fitzgerald analyst Louise Chen initiates coverage on Novo Nordisk (NYSE:NVO) with a Overweight rating and announces Price Target of $120.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment